Hippocratic AI vs IBM
Side-by-side comparison of AI visibility scores, market position, and capabilities
Safety-focused healthcare AI agents. $3.5B valuation. 115M+ clinical interactions, 99.38% accuracy. Polaris 4.2T-param architecture. $404M raised. Founded 2023, Palo Alto.
About
Hippocratic AI was founded in 2023 with a singular safety-first mission: deploy AI agents in healthcare settings where accuracy is not negotiable and errors carry clinical consequence. The company built its Polaris architecture — a 4.2 trillion parameter ensemble model trained specifically for healthcare interactions — to achieve accuracy rates sufficient for real-world clinical deployment. The name Hippocratic directly invokes the medical ethics principle of "first, do no harm," anchoring the company's product philosophy around safety validation before scale.\n\nHippocratic's AI agents are deployed for patient engagement, care navigation, chronic disease management, and administrative workflows across health systems, payers, and pharmaceutical companies. Its agents conduct voice and text-based interactions with patients — scheduling, medication adherence reminders, post-discharge follow-up, and clinical trial recruitment — at a cost and scale that human staffing cannot match. The platform's 99.38% accuracy rate across 115M+ clinical interactions represents the evidence base the company presents to health system procurement teams evaluating AI for direct patient-facing roles.\n\nHippocratic AI achieved a $3.5B valuation on $404M in total funding, making it one of the most highly valued healthcare AI companies globally just two years after founding. The company's rapid ascent reflects both the severity of the healthcare workforce shortage and the readiness of health system buyers to deploy AI agents for defined, bounded clinical workflows. Hippocratic competes with health AI platforms from Epic, Microsoft, and Google, differentiating through its safety-first architecture, purpose-built healthcare training data, and validated clinical accuracy metrics.
Armonk NY hybrid cloud and enterprise AI (NYSE: IBM) at $62.8B revenue; $6B+ generative AI bookings, record $12.7B free cash flow 2024, DataStax acquisition for watsonx vector database competing with Microsoft Azure for enterprise AI.
About
International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 component — providing hybrid cloud infrastructure, artificial intelligence software, and enterprise IT consulting through approximately 270,300 employees in 170 countries with $62.8 billion in annual revenue. Founded on June 16, 1911, as Computing-Tabulating-Recording Company through a merger orchestrated by financier Charles Ranlett Flint, renamed IBM in 1924 under Thomas Watson Sr., IBM has undergone multiple strategic transformations over its 110+ year history: building the System/360 mainframe platform (1964), launching the IBM PC (1981), selling the PC division to Lenovo (2005, $1.75B), and completing the $34 billion Red Hat acquisition (2019) that repositioned IBM as a hybrid cloud platform company. CEO Arvind Krishna (appointed April 2020) has focused IBM's strategy on three areas: hybrid cloud (powered by Red Hat OpenShift, the enterprise Kubernetes platform), AI (the watsonx platform for enterprise AI model development and deployment), and enterprise consulting. Under Krishna, IBM recorded $12.7 billion in free cash flow in 2024 (a company record), surpassed $6 billion in generative AI bookings since June 2023, and saw the stock price double — trading at all-time highs through 2024-2025. IBM announced the DataStax acquisition in 2025 to deepen watsonx's data layer with AstraDB (vector database for AI applications), DataStax Enterprise (Apache Cassandra), and Langflow (low-code AI agent development).
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.